NasdaqGM - Nasdaq Real Time Price USD
Nurix Therapeutics, Inc. (NRIX)
12.85
+0.31
+(2.48%)
As of 12:20:15 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| HANSEN GWENN Officer | Sale | Apr 30, 2025 | 61,516 |
| KUNKEL LORI ANNE Director | Stock Gift | Jul 17, 2024 | 0 |
| RING CHRISTINE Officer | Sale | Apr 30, 2025 | 37,318 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale | May 2, 2025 | 33,724 |
Related Tickers
RLAY Relay Therapeutics, Inc.
3.5550
+5.80%
ITOS iTeos Therapeutics, Inc.
10.00
-0.40%
KYMR Kymera Therapeutics, Inc.
48.52
+2.88%
CCCC C4 Therapeutics, Inc.
1.6550
-1.49%
KURA Kura Oncology, Inc.
6.85
+1.78%
RVMD Revolution Medicines, Inc.
41.51
+2.28%
CGEM Cullinan Therapeutics, Inc.
9.01
+2.86%
ORIC ORIC Pharmaceuticals, Inc.
9.80
-0.61%
PTGX Protagonist Therapeutics, Inc.
56.85
+2.10%
SRRK Scholar Rock Holding Corporation
34.23
+0.47%